BRVENasdaqManufacturing

Braveheart Bio, Inc. (BRVE) earnings date, market-implied expected move, and options open interest by expiry

20.83

−0.36 · −1.68%

post 21.54 +3.36%

Closed15:59 ET

Open20.90Volume533,667Mkt cap$159.2M

Day20.90 – 21.53100%52-wk17.86 – 32.0026%

BRVE

Braveheart Bio, Inc.

OpenVolumeMkt capP/EEPSDiv yield

Day – 52-wk –

Expected move

No implied move.

Next report

—

Calendar

Last report

−1.70%

shaded = implied · ▲▼ = realized

Sep 8 '26 · confirmed

Implied vs realized

Largest filed tie

—

13F top-10 QoQ

—

Top fund weight

—

Last reportshaded = implied▲▼ = realized× = |realized| ÷ implied

No upcoming report date for Braveheart Bio (BRVE). No implied move.

Implied vs realized

1 report

—≥ implied

Q2 FY26Sep 8 '26confirmed—▼−1.70%—

quarterimplied−5%0+5%realized×

Q2 FY26—▼−1.70%—

Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Implied vs realized

Positioning

No open-interest data.

Positioning

Linked exposure

No linked exposure.

Linked exposure

Revenue flow

No filed income statement.

Revenue flow

Intraday

15m bars

Hatch = extended hours · ▯ up · ▮ downSource: market data · 15:45 ET

Intraday

Event sensitivity

—

Earnings history

EPS -2.51 · consensus —

Quarter	Reported	EPS	Consensus
Q2 FY26	Sep 8 '26 · confirmed	-2.51	—

Source: filed financials

Methodology

ties · implied moves · holdersMethod